NeuroBo Pharmaceuticals Cash from Investing (TTM) Analysis

NeuroBo Pharmaceuticals Inc (NRBO)

3.78 +0.05 (+1.34%) USD | NASDAQ | May 03, 16:00

3.75 -0.03 (-0.79%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-0.05M
September 30, 2023	-0.041M
June 30, 2023	-0.004M
March 31, 2023	0.004M
December 31, 2022	0.008M
September 30, 2022	-0.575M
June 30, 2022	-0.575M
March 31, 2022	-0.586M
December 31, 2021	-0.586M
September 30, 2021	0.068M
June 30, 2021	0.068M
March 31, 2021	0.071M
December 31, 2020	0.069M
September 30, 2020	-5.941M
June 30, 2020	-6.034M
March 31, 2020	-6.059M
December 31, 2019	-6.057M

Date	Value
September 30, 2019	-0.121M
June 30, 2019	-0.028M
March 31, 2019	-0.003M
December 31, 2018	-0.003M
September 30, 2018	0.00
June 30, 2018	0.00
March 31, 2018	0.00
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-6.059M

Minimum

Mar 2020

0.071M

Maximum

Mar 2021

-1.388M

Average

-0.05M

Median

Dec 2023

Cash from Investing (TTM) Benchmarks